Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N.
Kourelis TV, et al.
Am J Hematol. 2016 Nov;91(11):1123-1128. doi: 10.1002/ajh.24528. Epub 2016 Aug 29.
Am J Hematol. 2016.
PMID: 27501122
Free article.
Recent reports suggest that deep hematologic responses to chemotherapy are associated with improved renal outcomes in monoclonal immunoglobulin deposition disease (MIDD). Here we describe the long term outcomes and identify prognostic factors after fir …
Recent reports suggest that deep hematologic responses to chemotherapy are associated with improved renal outcomes in monoclonal i …